Works matching IS 03407004 AND DT 2002 AND VI 51 AND IP 1
Results: 8
Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 45, doi. 10.1007/s00262-001-0255-1
- By:
- Publication type:
- Article
Progress in vaccination against cancer (PIVAC) 2001, Robinson College, University of Cambridge, UK.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 58, doi. 10.1007/s00262-001-0252-4
- By:
- Publication type:
- Article
Binding to CD20 by Anti-B1 Antibody or F(ab')<sub>2</sub> is sufficient for induction of apoptosis in B-cell lines.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 15, doi. 10.1007/s00262-001-0247-1
- By:
- Publication type:
- Article
The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 53, doi. 10.1007/s00262-001-0250-6
- By:
- Publication type:
- Article
A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 33, doi. 10.1007/s00262-001-0245-3
- By:
- Publication type:
- Article
Generation of activated and antigen-specific T cells with cytotoxic activity after co-culture with dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 25, doi. 10.1007/s00262-001-0251-5
- By:
- Publication type:
- Article
Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 9, doi. 10.1007/s00262-001-0249-z
- By:
- Publication type:
- Article
Killing activity of human umbilical cord blood-derived TCRValpha24<sup>+</sup> NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 1, doi. 10.1007/s00262-001-0246-2
- By:
- Publication type:
- Article